Singapore Medical Group strengthens presence in the Asia-Pacific region with controlling stake in leading Australian IVF group

• As part of a corporate strategic initiative to enhance SMG's business portfolio and streamline the organizational structure, SMG will acquire a controlling stake in Australia's City Fertility from Korea's CHA Healthcare in exchange for additional shares in TLW, the sole shareholder of SMG
• CHA Healthcare, which owns an existing equity interest of 42.4% in TLW, will see its stake increase to 64.2% as the strengthened CHA-SMG partnership looks to accelerate strategic growth initiatives in APAC
• Transaction will significantly enhance shareholder value for TLW's existing shareholders with 300%+ increase in EPS and 30%+ increase in NAV per share
• Following SMG's delisting from the SGX-ST, this latest initiative solidifies SMG's positioning as a major pan-Pacific healthcare group with operations in four countries and broadened service offerings in IVF and Women's Health
• Leveraging CHA's industry-leading fertility and women's health expertise, CHA-SMG partnership to continue exploring growth opportunities in new APAC markets to meet rising demand for high-quality reproductive treatments and family-centric healthcare

SINGAPORE, Aug. 16, 2024 /PRNewswire/ -- TLW Success Limited ("TLW" or the "Company"), the holding company of the former SGX-listed Singapore Medical Group ("SMG" or the "Group"), has today announced a corporate reshuffling initiative with its largest shareholder, CHA Healthcare Singapore Pte Ltd ("CHA Asia").